Search Results - "KANEKO, Yasuhiko"

Refine Results
  1. 1

    Trim32 facilitates degradation of MYCN on spindle poles and induces asymmetric cell division in human neuroblastoma cells by Izumi, Hideki, Kaneko, Yasuhiko

    Published in Cancer research (Chicago, Ill.) (01-10-2014)
    “…Asymmetric cell division (ACD) is a physiologic process during development and tissue homeostasis. ACD produces two unequal daughter cells: one has…”
    Get full text
    Journal Article
  2. 2

    Evidence of asymmetric cell division and centrosome inheritance in human neuroblastoma cells by Izumi, Hideki, Kaneko, Yasuhiko

    “…Asymmetric cell division (ACD) is believed to be a physiological event that occurs during development and tissue homeostasis in a large variety of organisms…”
    Get full text
    Journal Article
  3. 3

    The Role of MYCN in Symmetric vs. Asymmetric Cell Division of Human Neuroblastoma Cells by Izumi, Hideki, Kaneko, Yasuhiko, Nakagawara, Akira

    Published in Frontiers in oncology (21-10-2020)
    “…Asymmetric cell division (ACD) is an important physiological event in the development of various organisms and maintenance of tissue homeostasis. ACD produces…”
    Get full text
    Journal Article
  4. 4

    Recycling endosomal CD133 functions as an inhibitor of autophagy at the pericentrosomal region by Izumi, Hideki, Li, Yuanyuan, Shibaki, Masami, Mori, Daisuke, Yasunami, Michio, Sato, Seiji, Matsunaga, Hisashi, Mae, Takao, Kodama, Kenji, Kamijo, Takehiko, Kaneko, Yasuhiko, Nakagawara, Akira

    Published in Scientific reports (19-02-2019)
    “…CD133 is a transmembranous protein that mainly localises to the plasma membrane in haematopoietic and neural stem cells as well as cancer stem cells. Although…”
    Get full text
    Journal Article
  5. 5

    Molecular Regulation of Autophagy and Asymmetric Cell Division by Cancer Stem Cell Marker CD133 by Izumi, Hideki, Kaneko, Yasuhiko, Nakagawara, Akira

    Published in Cells (Basel, Switzerland) (01-03-2023)
    “…CD133, also called prominin-1, is widely known as a cancer stem cell marker, and its high expression correlates with a poor prognosis in many cancers. CD133…”
    Get full text
    Journal Article
  6. 6

    Analysis of Asymmetric Cell Division Using Human Neuroblastoma Cell Lines as a Model System by Izumi, Hideki, Kaneko, Yasuhiko, Nakagawara, Akira

    Published in Symmetry (Basel) (01-10-2021)
    “…Neuroblastoma is one of the most common childhood solid tumors and develops from neural stem cells that normally comprise the embryonic structure termed the…”
    Get full text
    Journal Article
  7. 7

    Outcome of renal tumors registered in Japan Wilms Tumor Study‐2 (JWiTS‐2): A report from the Japan Children's Cancer Group (JCCG) by Koshinaga, Tsugumichi, Takimoto, Tetsuya, Oue, Takaharu, Okita, Hajime, Tanaka, Yukichi, Nozaki, Miwako, Tsuchiya, Kunihiko, Inoue, Eisuke, Haruta, Masayuki, Kaneko, Yasuhiko, Fukuzawa, Masahiro

    Published in Pediatric blood & cancer (01-07-2018)
    “…Background Japan Wilms Tumor Study‐2 (JWiTS‐2) mandated central pathology review for all case registrations. The study aimed to compare the outcomes of…”
    Get full text
    Journal Article
  8. 8

    Kasumi leukemia cell lines: characterization of tumor genomes with ethnic origin and scales of genomic alterations by Kasai, Fumio, Asou, Hiroya, Ozawa, Midori, Kobayashi, Kazuhiko, Kuramitsu, Hiroyuki, Satoh, Motonobu, Kohara, Arihiro, Kaneko, Yasuhiko, Kawamura, Machiko

    “…Kasumi-1 has played an important role in an experimental model with t(8;21) translocation, which is a representative example of leukemia cell lines. However,…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Clinical prognostic value of DNA methylation in hepatoblastoma: Four novel tumor suppressor candidates by Honda, Shohei, Minato, Masashi, Suzuki, Hiromu, Fujiyoshi, Masato, Miyagi, Hisayuki, Haruta, Masayuki, Kaneko, Yasuhiko, Hatanaka, Kanako C., Hiyama, Eiso, Kamijo, Takehiko, Okada, Tadao, Taketomi, Akinobu

    Published in Cancer science (01-06-2016)
    “…Hepatoblastoma (HB) is very rare but the most common malignant neoplasm of the liver occurring in children. Despite improvements in therapy, outcomes for…”
    Get full text
    Journal Article
  12. 12

    Blastemal predominant type Wilms tumor in Japan: Japan Children's Cancer Group by Koshinaga, Tsugumichi, Takimoto, Tetsuya, Okita, Hajime, Tanaka, Yukichi, Inoue, Eisuke, Oue, Takaharu, Nozaki, Miwako, Tsuchiya, Kunihiko, Haruta, Masayuki, Kaneko, Yasuhiko, Fukuzawa, Masahiro

    Published in Pediatrics international (01-04-2019)
    “…Background Persistence of blastemal components after chemotherapy is a marker of poor outcome in Wilms tumor (WT). Recent reports from local Japanese areas…”
    Get full text
    Journal Article
  13. 13

    RASSF1A methylation may have two biological roles in neuroblastoma tumorigenesis depending on the ploidy status and age of patients by Haruta, Masayuki, Kamijo, Takehiko, Nakagawara, Akira, Kaneko, Yasuhiko

    Published in Cancer letters (28-06-2014)
    “…Abstract RASSF1A methylation was frequent in neuroblastomas found in infants by mass-screening or infants and children diagnosed clinically, whereas CASP8 and…”
    Get full text
    Journal Article
  14. 14

    NM23 downregulation and lysophosphatidic acid receptor EDG2/lpa1 upregulation during myeloid differentiation of human leukemia cells by Okabe-Kado, Junko, Hagiwara-Watanabe, Yuki, Niitsu, Nozomi, Kasukabe, Takashi, Kaneko, Yasuhiko

    Published in Leukemia research (01-03-2018)
    “…A common mechanism for inhibition of leukemia cell myeloid differentiation and breast cancer cell motility involving NM23 and EDG2. [Display omitted] •NM23…”
    Get full text
    Journal Article
  15. 15

    Bilateral Wilms tumors treated according to the Japan Wilms Tumor Study Group protocol by Oue, Takaharu, Koshinaga, Tsugumichi, Okita, Hajime, Kaneko, Yasuhiko, Hinotsu, Shiro, Fukuzawa, Masahiro

    Published in Pediatric blood & cancer (01-07-2014)
    “…Background The introduction of multimodal therapy has improved the survival rate of bilateral Wilms tumors (BWT); however, the results are still not…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Extracellular NM23 protein promotes the growth and survival of primary cultured human acute myelogenous leukemia cells by Okabe‐Kado, Junko, Kasukabe, Takashi, Honma, Yoshio, Kobayashi, Hirofumi, Maseki, Nobuo, Kaneko, Yasuhiko

    Published in Cancer science (01-10-2009)
    “…An elevated serum level of NM23‐H1 protein is found in acute myelogenous leukemia (AML), and predicts a poor treatment outcome in AML patients. To investigate…”
    Get full text
    Journal Article
  18. 18

    Ellagic acid, a natural polyphenolic compound, induces apoptosis and potentiates retinoic acid-induced differentiation of human leukemia HL-60 cells by Hagiwara, Yuki, Kasukabe, Takashi, Kaneko, Yasuhiko, Niitsu, Nozomi, Okabe-Kado, Junko

    Published in International journal of hematology (01-07-2010)
    “…All-trans retinoic acid (ATRA) is a standard drug used for differentiation therapy in acute promyelocytic leukemia. To potentiate this therapy, we examined the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Management of pediatric renal tumor: Past and future trials of the Japan Wilms Tumor Study Group by Oue, Takaharu, Fukuzawa, Masahiro, Koshinaga, Tsugumichi, Okita, Hajime, Nozaki, Miwako, Chin, Motoki, Kaneko, Yasuhiko, Tanaka, Yukichi, Haruta, Masayuki, Tsuchiya, Kunihiko, Kuwajima, Shigeko, Takimoto, Tetsuya

    Published in Pediatrics international (01-10-2015)
    “…The Japan Wilms Tumor Study group (JWiTS) was founded in 1996 to improve outcomes for children with renal tumor in Japan, and a nationwide multicenter…”
    Get full text
    Journal Article